Bipolar Disorder  >>  Vraylar (cariprazine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie
NCT00488618: Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania

Completed
2
238
US
Cariprazine (RGH-188), Placebo
Forest Laboratories, Gedeon Richter Ltd.
Bipolar Disorder
07/08
07/08
NCT00852202: Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Completed
2
234
US
cariprazine, placebo
Forest Laboratories, Gedeon Richter Ltd.
Bipolar Depression
06/10
06/10
NCT01396447 / 2011-002334-39: Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Completed
2
584
US, Canada, Europe, RoW
Placebo, Cariprazine
Forest Laboratories, Gedeon Richter Ltd.
Depression, Bipolar
01/14
01/14

Download Options